1-acetyl-3,5-diphenyl-4,5-dihydro-(1h)-pyrazole and bekanamycin

1-acetyl-3,5-diphenyl-4,5-dihydro-(1h)-pyrazole has been researched along with bekanamycin in 1 studies

Compound Research Comparison

Studies (1-acetyl-3,5-diphenyl-4,5-dihydro-(1h)-pyrazole)	Trials (1-acetyl-3,5-diphenyl-4,5-dihydro-(1h)-pyrazole)	Recent Studies (post-2010) (1-acetyl-3,5-diphenyl-4,5-dihydro-(1h)-pyrazole)	Studies (bekanamycin)	Trials (bekanamycin)	Recent Studies (post-2010) (bekanamycin)
13	0	3	118	4	39

Protein Interaction Comparison

Protein	Taxonomy	1-acetyl-3,5-diphenyl-4,5-dihydro-(1h)-pyrazole (IC50)	bekanamycin (IC50)
3-oxoacyl-[acyl-carrier-protein] synthase 3	Escherichia coli		6.3

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Luo, Y; Lv, PC; Sun, J; Yang, Y; Zhu, HL	1

Other Studies

1 other study(ies) available for 1-acetyl-3,5-diphenyl-4,5-dihydro-(1h)-pyrazole and bekanamycin

Article	Year
Design, synthesis, and structure-activity relationships of pyrazole derivatives as potential FabH inhibitors. Bioorganic & medicinal chemistry letters, 2010, Aug-01, Volume: 20, Issue:15 Topics: 3-Oxoacyl-(Acyl-Carrier-Protein) Synthase; Anti-Bacterial Agents; Binding Sites; Computer Simulation; Drug Design; Enzyme Inhibitors; Escherichia coli Proteins; Pyrazoles; Structure-Activity Relationship	2010

Article

Year

Design, synthesis, and structure-activity relationships of pyrazole derivatives as potential FabH inhibitors.

Bioorganic & medicinal chemistry letters, 2010, Aug-01, Volume: 20, Issue:15

Topics: 3-Oxoacyl-(Acyl-Carrier-Protein) Synthase; Anti-Bacterial Agents; Binding Sites; Computer Simulation; Drug Design; Enzyme Inhibitors; Escherichia coli Proteins; Pyrazoles; Structure-Activity Relationship

2010